Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)
all should be discontinued when pregnancy is recognized) [1] [4] After prolonged treatment interruptions (typically 2 consecutive missed doses or longer gaps), re-titration from the initial dose may be necessary according to product-specific guidelines to minimize gastrointestinal side effects
If dietary assessment confirms insufficient intake, calcium supplementation (500600 milligrams daily) may be warranted, preferably taken separately from iron supplements to optimise absorption
In the context of kidney stones, obesity increases urinary excretion of calcium, oxalate, and uric acid whilst decreasing urinary pH, creating conditions favourable for stone formation
